Article Details
Retrieved on: 2024-11-20 15:39:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes CytoMed Therapeutics' advancement in biopharma through the ANGELICA Trial in Singapore, focusing on innovative CAR-T cell therapies using donor-derived gamma delta T cells for cancer. The focus is on cutting-edge biotechnology and cell therapy applications. Tags like 'Immunotherapy' and 'Singapore' underscore the context of this biopharma development.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here